Zacks Research Issues Positive Forecast for Itron Earnings

Itron, Inc. (NASDAQ:ITRI) – Equities researchers at Zacks Research upped their Q3 2026 earnings per share (EPS) estimates for shares of Itron in a research report issued to clients and investors on Tuesday, August 18th. Zacks Research analyst Team now forecasts that the scientific and technical instruments company will post earnings of $1.55 per share for the quarter, up from their previous forecast of $1.52. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $6.43 per share. Zacks Research also issued estimates for Itron’s Q4 2026 earnings at $1.72 EPS, FY2026 earnings at $6.35 EPS, Q1 2027 earnings at $1.49 EPS, Q3 2027 earnings at $1.50 EPS, FY2027 earnings at $5.90 EPS, Q1 2028 earnings at $1.78 EPS and Q2 2028 earnings at $1.87 EPS.

Several other brokerages have also recently commented on ITRI. Needham & Company LLC boosted their target price on shares of Itron from $116.00 to $128.00 and gave the company a “buy” rating in a research report on Wednesday, July 29th. Raymond James Financial began coverage on shares of Itron in a research note on Tuesday, April 21st. They issued an “underperform” rating on the stock. Seaport Research Partners restated a “buy” rating and set a $150.00 price objective on shares of Itron in a research report on Wednesday, July 29th. Weiss Ratings restated a “hold (c)” rating on shares of Itron in a research note on Wednesday, August 5th. Finally, Stephens restated an “overweight” rating and set a $130.00 price objective on shares of Itron in a research report on Wednesday, May 20th. Eight investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $131.33.

Itron Trading Down 4.4%

ITRI opened at $96.18 on Wednesday. The stock has a market capitalization of $4.21 billion, a price-to-earnings ratio of 16.06, a P/E/G ratio of 0.83 and a beta of 1.30. The company has a quick ratio of 2.29, a current ratio of 2.75 and a debt-to-equity ratio of 0.96. Itron has a twelve month low of $77.77 and a twelve month high of $142.00. The company has a 50-day simple moving average of $89.39 and a 200 day simple moving average of $90.12.

Itron (NASDAQ:ITRI) last released its earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.29 by $0.30. Itron had a return on equity of 19.26% and a net margin of 11.90%.The company had revenue of $562.90 million for the quarter, compared to analyst estimates of $566.34 million. During the same period in the prior year, the firm posted $1.62 EPS. Itron’s quarterly revenue was down 7.2% on a year-over-year basis. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS.

Insider Transactions at Itron

In related news, CFO Joan S. Hooper sold 442 shares of Itron stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total transaction of $37,291.54. Following the completion of the transaction, the chief financial officer owned 117,478 shares of the company’s stock, valued at $9,911,618.86. This trade represents a 0.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP John F. Marcolini sold 322 shares of the company’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total transaction of $27,167.14. Following the sale, the senior vice president directly owned 24,689 shares in the company, valued at $2,083,010.93. This trade represents a 1.29% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 2,290 shares of company stock worth $192,355 over the last three months. 1.77% of the stock is owned by company insiders.

Institutional Investors Weigh In On Itron

Several large investors have recently added to or reduced their stakes in ITRI. Employees Retirement System of Texas bought a new position in shares of Itron during the 3rd quarter worth approximately $32,000. Private Trust Co. NA lifted its position in shares of Itron by 112.4% during the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after acquiring an additional 145 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in Itron by 343.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after acquiring an additional 268 shares in the last quarter. Advisory Services Network LLC acquired a new stake in Itron in the third quarter worth $49,000. Finally, EverSource Wealth Advisors LLC increased its stake in Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after purchasing an additional 81 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Trending Headlines about Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Zacks upgraded ITRI’s status to Rank #1 (Strong Buy) on August 19 and included the company on its strong-buy and best-value stock lists. The upgrade reflects improving earnings-estimate trends and could support investor demand. New Strong Buy Stocks for August 19th
• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast to $6.35 from $5.97, while increasing estimates for Q3 2026 to $1.55, Q4 2026 to $1.72, Q1 2027 to $1.49, Q3 2027 to $1.50, and FY2027 to $5.90. These revisions suggest stronger expected profitability across several upcoming periods. Itron analyst estimate revisions
• Positive Sentiment: Analysts’ average price target reportedly implies approximately 27% upside from the recent share price, although price targets are not reliable guarantees. Itron also recently exceeded quarterly EPS expectations, reporting $1.59 versus the $1.29 consensus estimate. Wall Street analysts price target for Itron
• Neutral Sentiment: Zacks Research trimmed its Q2 2028 EPS estimate to $1.87 from $1.97. The reduction is relatively distant but indicates that the positive revisions are not uniform. Zacks maintains a Hold rating, while the broader analyst view is described as Moderate Buy.
• Negative Sentiment: Itron’s latest quarter showed revenue of $562.9 million, slightly below estimates and down 7.2% year over year. The stock also recently closed at $96.30 after a 4.4% decline, underscoring continued volatility despite the improved earnings outlook. Itron stock decline and GF Value analysis

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.